Cho, Sung Joon <br/><br/>
Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial.  [electronic resource] 

 -  Progress in neuro-psychopharmacology & biological psychiatry  Jan 2011 
 - 208-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1878-4216 
<br/><br/><label>Standard No.: </label>10.1016/j.pnpbp.2010.11.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antidepressive Agents, Tricyclic--therapeutic use<br/>Antipsychotic Agents--therapeutic use<br/>Cognition Disorders--drug therapy<br/>Double-Blind Method<br/>Drug Synergism<br/>Female<br/>Humans<br/>Male<br/>Mianserin--analogs & derivatives<br/>Middle Aged<br/>Mirtazapine<br/>Psychiatric Status Rating Scales<br/>Retrospective Studies<br/>Risperidone--therapeutic use<br/>Schizophrenia--complications